Few outpatients with influenza are prescribed antivirals, while antibiotic prescribing is more frequent, according to a study published online July 16 in Clinical Infectious Diseases.
Several new remote patient monitoring devices with useful applications are available or under development, according to an article published July 8 in Medical Economics.
Patient reviews indicate that the attributes most valued in physicians include interpersonal skills and bedside manner, according to a report published online July 16 by Vitals.
By Adam Hochron
Researchers at Temple University believe they have found a way to help remove any traces of HIV-1 from a person’s body as work continues toward a cure for the virus.
For HIV-infected patients with abdominal fat accumulation, the growth hormone-releasing hormone analog tesamorelin is associated with reductions in visceral fat and modest reductions in liver fat, according to a study published in the July 23/30 issue of the Journal of the American Medical Association, a theme issue on HIV/AIDS. This issue has been released early to coincide with AIDS 2014, the International AIDS Conference, held from July 20 to 25 in Melbourne, Australia.
Most US physicians are satisfied, with satisfied physicians more likely to report positive trends in medicine, according to a report published by Jackson Healthcare.
Community hospitals in the southeastern United States have seen a five-fold increase in the number of cases of drug-resistant carbapenem-resistant Enterobacteriaceae during the past five years, according to a new study published in the August issue of Infection Control and Hospital Epidemiology.
Only 1 in 5 sexually active U.S. teens have been tested for HIV, a new government report shows. The U.S. Centers for Disease Control and Prevention report, which looked at data from 1991 to 2013, is to be presented July 23 at AIDS 2014, the International AIDS Conference, held from July 20 to 25 in Melbourne, Australia.
An HIV treatment regimen of a boosted protease inhibitor combined with nucleoside reverse-transcriptase inhibitors is safe and effective in low-resource settings, according to a study published in the July 17 issue of the New England Journal of Medicine.
By Adam Hochron
The US Food and Drug Administration recently approved a new drug aimed to aid the thousands of Americans affected by hereditary angioedema.